Clinical Trial Update: Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with amifostine to treat malignant germ cell tumors in children; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Germ Cell Tumor
• Ovarian Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ | Phase 2 | Status: COMPLETED